Brian Wright
Stock Analyst at Roth MKM
(0.48)
# 4,198
Out of 5,147 analysts
31
Total ratings
27.59%
Success rate
-21.99%
Average return
Main Sectors:
Stocks Rated by Brian Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIOX Bioceres Crop Solutions | Maintains: Buy | $20 → $21 | $0.56 | +3,650.00% | 5 | Feb 9, 2024 | |
| ANDE The Andersons | Reiterates: Buy | $65 | $65.29 | -0.44% | 3 | Feb 6, 2024 | |
| BG Bunge Global | Maintains: Buy | $161 → $138 | $120.65 | +14.38% | 2 | Feb 5, 2024 | |
| ADM Archer-Daniels-Midland Company | Downgrades: Neutral | $98 → $66 | $69.04 | -4.40% | 2 | Jan 22, 2024 | |
| FMC FMC Corporation | Initiates: Buy | $74 | $14.74 | +402.04% | 1 | Jan 4, 2024 | |
| CTVA Corteva | Maintains: Buy | $82 → $63 | $80.12 | -21.37% | 2 | Nov 22, 2023 | |
| LNN Lindsay | Upgrades: Buy | $128 → $150 | $134.70 | +11.36% | 3 | Oct 23, 2023 | |
| PAHC Phibro Animal Health | Reiterates: Buy | $21 | $54.59 | -61.53% | 3 | Sep 1, 2023 | |
| UGRO urban-gro | Reiterates: Buy | $275 | $2.48 | +10,988.71% | 2 | Sep 1, 2023 | |
| XXII 22nd Century Group | Reiterates: Buy | $3,726,000 | $4.57 | +81,531,628.67% | 2 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $60 | $0.88 | +6,735.27% | 3 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $39 | $1.52 | +2,465.79% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $297 | $459.93 | -35.42% | 1 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $0.97 | +12,271.13% | 1 | Oct 8, 2021 |
Bioceres Crop Solutions
Feb 9, 2024
Maintains: Buy
Price Target: $20 → $21
Current: $0.56
Upside: +3,650.00%
The Andersons
Feb 6, 2024
Reiterates: Buy
Price Target: $65
Current: $65.29
Upside: -0.44%
Bunge Global
Feb 5, 2024
Maintains: Buy
Price Target: $161 → $138
Current: $120.65
Upside: +14.38%
Archer-Daniels-Midland Company
Jan 22, 2024
Downgrades: Neutral
Price Target: $98 → $66
Current: $69.04
Upside: -4.40%
FMC Corporation
Jan 4, 2024
Initiates: Buy
Price Target: $74
Current: $14.74
Upside: +402.04%
Corteva
Nov 22, 2023
Maintains: Buy
Price Target: $82 → $63
Current: $80.12
Upside: -21.37%
Lindsay
Oct 23, 2023
Upgrades: Buy
Price Target: $128 → $150
Current: $134.70
Upside: +11.36%
Phibro Animal Health
Sep 1, 2023
Reiterates: Buy
Price Target: $21
Current: $54.59
Upside: -61.53%
urban-gro
Sep 1, 2023
Reiterates: Buy
Price Target: $275
Current: $2.48
Upside: +10,988.71%
22nd Century Group
Aug 23, 2023
Reiterates: Buy
Price Target: $3,726,000
Current: $4.57
Upside: +81,531,628.67%
Jul 21, 2023
Maintains: Buy
Price Target: $10 → $60
Current: $0.88
Upside: +6,735.27%
Apr 3, 2023
Maintains: Buy
Price Target: $78 → $39
Current: $1.52
Upside: +2,465.79%
Jun 3, 2022
Initiates: Buy
Price Target: $297
Current: $459.93
Upside: -35.42%
Oct 8, 2021
Initiates: Buy
Price Target: $120
Current: $0.97
Upside: +12,271.13%